PREVIOUS ARTICLENEXT ARTICLE
NEWS
By 3 November 2015 | Categories: news

0

It's nearing close to five months since Warner. Bros released Batman: Arkham Knight on next-gen consoles. Sadly though, the PC version suffered all manner of malady and had to be pulled subsequently. Unfortunately, the same fate has befallen the re-release version, which was readied for debut later this week, as more PC gamers have cited significant glitches and lags in gameplay.

As such, local distributor for the Batman gaming franchise, Ster-Kinekor Entertainment (SKE), has heeded the advice of Warner Bros. and decided not to re-release the game in South Africa. This means that local gamers will not find SKE distributed versions of the game in physical retail stores, but the company has stated that those still wishing to get the game can do so through Steam.

On that note, Steam has also taken to its community page to clarify the situation. Those that purchased the game via its site are subject for a full refund between now and the end of the year, but this is subject to a few caveats. As Engadget notes, only the Season Pass that accompanies the game is eligible for refund, and users cannot receive refunds on other separate DLC. Added to this, some PC gamers who purchased a retail copy of the game are reporting that the refund page will not load when prompted.

As such, this seems a terrible end for such a great gaming franchise. While we indeed sympathise with our PC brethren, the console versions of the game remain unscathed and a worthwhile purchase for any Dark Knight fans.

USER COMMENTS

Read
Magazine Online
TechSmart.co.za is South Africa's leading magazine for tech product reviews, tech news, videos, tech specs and gadgets.
Start reading now >
Download latest issue

Have Your Say


What new tech or developments are you most anticipating this year?
New smartphone announcements (44 votes)
Technological breakthroughs (28 votes)
Launch of new consoles, or notebooks (14 votes)
Innovative Artificial Intelligence solutions (28 votes)
Biotechnology or medical advancements (21 votes)
Better business applications (132 votes)